Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Jefferies; Says Takeover 'Increasingly Likely'

January 27, 2017 8:26 AM
Jefferies analyst Jeffrey Holford lowered estimates and his price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $69.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Rumors

Next Articles